Close X
Saturday, November 23, 2024
ADVT 
International

White House on U.S. vaccine supply: America first

Darpan News Desk The Canadian Press, 12 Feb, 2021 08:59 PM
  • White House on U.S. vaccine supply: America first

The White House is making no apologies for prioritizing Americans in its effort to distribute COVID-19 vaccines.

Press secretary Jen Psaki says President Joe Biden's focus is on ensuring that the American people get vaccinated.

That's despite the challenges faced by other countries, including Canada, in procuring vaccine doses from outside the United States.

 

pics

Psaki says Biden understands that widespread vaccination around the world is vital to getting the pandemic under control.

But she also says U.S. vaccine manufacturing capacity will be aimed primarily at domestic efforts.

The president has promised to administer 100 million shots before the end of his first 100 days in the White House.

MORE International ARTICLES

Prince Harry says ignorance no excuse for unconscious bias

Prince Harry says ignorance no excuse for unconscious bias
Harry talked about racial inequality and social justice in a video discussion with the Black Lives Matter activist Patrick Hutchinson as part of the GQ Heroes Conference, which is being broadcast this week.

Prince Harry says ignorance no excuse for unconscious bias

Halloween goes on at the White House with a few twists

Halloween goes on at the White House with a few twists
In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II